Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Opgen Inc (NQ: OPGN )

2.460 USD +0.170 (+7.42%)
Streaming Delayed Price Updated: 8:50 AM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Opgen Inc

< Previous 1 2 3 Next >
Thinking about buying stock in Aslan Pharmaceuticals, electroCore, Novan, OpGen, or Salarius Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for ASLN, ECOR, NOVN, OPGN, and SLRX. 
From PR Newswire
OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
From GlobeNewswire News Releases
OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction of Antibiotic Susceptibility Testing by Next-Generation Sequencing
From GlobeNewswire News Releases
OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules
From GlobeNewswire News Releases
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Business Update
From GlobeNewswire News Releases
OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for Colombia
From GlobeNewswire News Releases
Results from 1,400 Patient Sample Multicenter Study Published: Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract
From GlobeNewswire News Releases
OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
From GlobeNewswire News Releases
OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Presents Update at Scientific Conferences, Expects Granting of Key Patent
From GlobeNewswire News Releases
OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
From GlobeNewswire News Releases
OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service for Native Specimens and Receives Bulk Order from Public Health Agency
From GlobeNewswire News Releases
OpGen Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
OpGen to Provide Business Update and Financial Results for the Third Quarter 2020
From GlobeNewswire News Releases
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators
From GlobeNewswire News Releases
OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020
From GlobeNewswire News Releases
OpGen Issues Formal Response to FDA’s Requests for Additional Information and Expects Near Term FDA Clearance Decision for Acuitas AMR Gene Panel
From GlobeNewswire News Releases
OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud
From GlobeNewswire News Releases
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators
From GlobeNewswire News Releases
OpGen Announces Successful Completion of Study Collaboration with Karolinska Institutet on Bacterial Co-Infections in COVID-19 Pneumonia Patients and Presents Data on Unyvero HPN Panel at ECCVID 2020
From GlobeNewswire News Releases
OpGen, Inc. Announces Notice of Annual Meeting Venue Change
From GlobeNewswire News Releases
Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for Investigation of Genetic Antimicrobial Resistance Mec
From GlobeNewswire News Releases
OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility Test
From GlobeNewswire News Releases
Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Tract (LRT) Panel is Likely to Alter Antibiotic Management of Significant Numbers of Patients Presenting with Suspected Pneumon
From GlobeNewswire News Releases
OpGen, Inc. (Nasdaq: OPGN) could hit $10+ this week on the latest breaking news of their CE mark certification
Tags Biotech
From Issuewire
Thinking about buying stock in Plug Power, OpGen Inc, Allied Esports Entertainment, AMC Entertainment, or 9 Meters Biopharma?
InvestorsObserver issues critical PriceWatch Alerts for PLUG, OPGN, AESE, AMC, and NMTR. 
From PR Newswire
OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19
From GlobeNewswire News Releases
OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers
From GlobeNewswire News Releases
US Stocks That Surged Higher: $CNDT $GRPN $OPGN
Tags The Market Signal
From The Market Signal
OpGen Co-Markets COVID-19 Antibody Test Kit
From GlobeNewswire News Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.